Camtek Ltd. (NASDAQ:CAMT) Stock Has Average Target Price of $164.00 According to Analysts

Shares of Camtek Ltd. (NASDAQ:CAMT) have been assigned a consensus recommendation of “Hold” from the fourteen research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $164.00.

CAMT has been the subject of a number of research reports. Needham & Company LLC decreased their target price on shares of Camtek from $170.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, November 4th. Stifel Nicolaus set a $140.00 target price on Camtek in a research report on Wednesday, November 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Camtek in a research note on Wednesday, November 4th. B. Riley Financial reduced their price objective on Camtek from $166.00 to $138.00 and set a “buy” rating on the stock in a report on Monday. Finally, Morgan Stanley cut Camtek from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $152.00 to $126.00 in a research note on Monday, November 2nd.

Insider Activity

In other Camtek news, VP Orit Geva-Dvash sold 508 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $175.00, for a total transaction of $88,900.00. Following the transaction, the vice president directly owned 5,205 shares of the company’s stock, valued at $910,875. This trade represents a 8.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 79.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Camtek

Large investors have recently bought and sold shares of the stock. Migdal Insurance & Financial Holdings Ltd. increased its stake in Camtek by 15.6% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,060,896 shares of the semiconductor company’s stock valued at $475,204,000 after purchasing an additional 412,500 shares during the period. Harel Insurance Investments & Financial Services Ltd. grew its holdings in shares of Camtek by 38.2% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,302,009 shares of the semiconductor company’s stock worth $349,008,000 after acquiring an additional 636,773 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Camtek by 13.1% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,130,993 shares of the semiconductor company’s stock valued at $329,760,000 after buying an additional 246,885 shares in the last quarter. Phoenix Financial Ltd. increased its stake in shares of Camtek by 746.3% during the 3rd quarter. Phoenix Financial Ltd. now owns 2,013,214 shares of the semiconductor company’s stock worth $311,938,000 after purchasing an additional 1,775,319 shares in the last quarter. Finally, Y.D. More Investments Ltd raised its holdings in shares of Camtek by 20.8% in the first quarter. Y.D. More Investments Ltd now owns 783,365 shares of the semiconductor company’s stock worth $114,901,000 after acquiring an additional 134,791 shares during the last quarter. Institutional investors and hedge funds own 41.93% of the company’s stock.

Camtek News Summary

Investors following CAMT have been watching these news items:

• Positive Sentiment: Recent coverage highlighted a record Q3 and a strengthened 2027 growth outlook, supporting the view that demand and business momentum remain favorable. Camtek stock: Record quarter strengthens 2027 growth outlook
• Negative Sentiment: Northland lowered its FY2026 EPS estimate to $3.25 from $3.35 and its Q4 2026 estimate to $1.04 from $1.09, tempering the otherwise stronger 2027 outlook. Camtek analyst estimates
• Negative Sentiment: Coverage also frames 2027 as an execution test: investors will look for Camtek to convert its growth outlook into results. B. Riley’s lowered expectations for the stock add to the cautious analyst backdrop. Camtek stock: Record Q3 revenue raises 2027 execution stakes B. Riley lowers expectations for Camtek stock

Camtek Trading Down 1.5%

NASDAQ:CAMT opened at $105.42 on Tuesday. The company has a fifty day moving average of $134.55 and a 200 day moving average of $155.27. Camtek has a 52 week low of $89.13 and a 52 week high of $215.99. The firm has a market capitalization of $4.92 billion, a P/E ratio of 39.93, a P/E/G ratio of 1.59 and a beta of 1.69. The company has a quick ratio of 5.18, a current ratio of 5.85 and a debt-to-equity ratio of 0.65.

Camtek (NASDAQ:CAMT) last announced its quarterly earnings results on Wednesday, November 4th. The semiconductor company reported $0.99 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.99. Camtek had a net margin of 24.56% and a return on equity of 21.38%. The company had revenue of $161.29 million for the quarter, compared to analysts’ expectations of $160.36 million. During the same quarter in the previous year, the company earned $0.82 earnings per share. Camtek’s quarterly revenue was up 28.0% on a year-over-year basis. On average, research analysts predict that Camtek will post 3.24 earnings per share for the current year.

About Camtek

Camtek Ltd. develops, manufactures and sells inspection and metrology equipment used in semiconductor manufacturing. Its systems help manufacturers detect defects and measure features on wafers and other components, supporting quality control as semiconductor devices become smaller and more complex. The company’s products serve applications including advanced packaging, memory, image sensors and other semiconductor processes. Camtek combines optical inspection hardware with software to analyze production data and identify issues during manufacturing.